DNA topoisomerase targeted anticancer agents: New trends and developments Journal Article

  

Authors:	Su, T. L.; Chou, T. C.; Watanabe, K. A.
Article Title:	DNA topoisomerase targeted anticancer agents: New trends and developments
Keywords:	cancer chemotherapy; leukemia; review; doxorubicin; nonhuman; solid tumor; drug targeting; topotecan; antineoplastic agent; bone marrow suppression; etoposide; camptothecin; antineoplastic activity; mitoxantrone; daunorubicin; dactinomycin; amsacrine; anthracycline derivative; camptothecin derivative; dna topoisomerase inhibitor; dna topoisomerase (atp hydrolysing); teniposide; acridine derivative; intestine injury; patent; dna topoisomerase; gyrase inhibitor; genistein; ellipticine; amonafide; elliptinium; emodin; anthraquinone derivative; human; etoposide derivative; intercalating agent; chrysophanic acid; mitonafide
Journal Title:	Expert Opinion on Therapeutic Patents
Volume:	2
Issue:	8
ISSN:	1354-3776
Publisher:	Informa Healthcare
Date Published:	1992-01-01
Start Page:	1121
End Page:	1139
Language:	English
DOI:	10.1517/13543776.2.8.1121
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026660375&doi=10.1517%2f13543776.2.8.1121&partnerID=40&md5=7f49f3346fee7db8a4333198ae4d3c4a
Notes:	Article -- Export Date: 30 July 2019 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/149702